Read More

Coya Therapeutics Announces Publication Of Potential Novel Blood Biomarker Data In Amyotrophic Lateral Sclerosis Patients That Accurately Reflect Therapeutic Responses When Treated with Regulatory T Cell Enhancing Therapies

Pathological hallmarks of ALS are characterized by alterations in inflammation and oxidative stress, with oxidative stress playing a critical role in neuronal damage. 4-hydroxy-2-nonenal (4-HNE) is a key mediator of

COYA

Read More

Sculptor Special Committee Responds To Revised Unsolicited Proposals From Bidder J Consortium; Latest Proposal Does Not Constitute A Superior Proposal; Board Reaffirms Recommendation With Respect To Proposed Transaction With Rithm

Latest Proposal Does Not Constitute a Superior Proposal; Board Reaffirms Recommendation With Respect to Proposed Transaction with Rithm Sculptor Capital Management, Inc. ("Sculptor" or the

RITM